Site
Reference N Study design Eligibility criteria Study dates PCB Exposure (PCB type if stated ) Other exposure Cohort deaths, ratio a (CI) Hi exp = Hi exp deaths, ratio † (CI) ______________________________________________________________________________________________________________________________________________________________________________________________ Canada, (Liss 1989) 1073: cohort > 1 year work -1985 1978 air samples 3-8 µg/m 3 Benzene 146, SMR 1.0 (0.8-1.1); Men ever in 24, SMR 0.8 (0.5-1.2); Ontario, 273 1960 Ontario, 273 -1976 ca 45, SMR 1.2 (0.9-1.6) high exp job cancer 6, SMR 0.8 transformer women (0.3-1.9), lymph & manufacture 800 men hemat cancer 2 SMR and repair 2.9 (0.3-12.4) Canada, (Yassi et al. 1994) 2222: cohort > 1 month work -1989 >27,000 gallons Askarels mineral oil, 63-171 b , SMR 0.7-1.1 (nss); Transformer 35, SMR 0.9 (0.6-1.2); transformer all men 1946-1975 used in mfg solvents cancer 18-36, SMR 0.8-1.2 assembly cancer 11, SMR 1.4 (0.7manufacture (nss);GI ca 6-17, SMR 2.5); GI cancer 5, SMR 2.3 0. 9-1.6 (nss); pancreas ca (0.7-5.3); pancreas cancer 5-11 SMR 2.9-7.6 (all ss) 4, SMR 9.8 (2.6-25)
Italy, Milan (Bertazzi et al. 1982) 1946-1977 air samples 227-1500 µg/m 3 cancer 492 SMR 1.0 (0.9-1.1); workers ca 381, SMR 1.0 (0.9-1.2); women, rectal 12, SMR 1.3 (0.7-2.3); rectal 8, SMR 1.2 (0.5-4062 liver 9, SMR 0.8 (0.4-1.5) 2.4); liver 8, SMR 1.0 men (0.4-1.9) _________________________________________________________________________________________________________________________________________________________________________________________ a. Odds ratio (OR), standardized mortality ratio (SMR), or relative risk (RR). b. Yassi used various eligibility criteria and calculated SMRs for each set.
